Current NHS post
Consultant Clinical Oncologist, Royal Surrey County Hospital NHS Foundation Trust.
- Royal College of Radiologists.
- Royal College of Physicians.
Dr Ezhil led the implementation of the SABR lung service at the Royal Surrey County Hospital (RSCH) in January 2012 and has treated over 150 patients to date. She is currently the SABR lead for the treatment of oligometastases at RSCH and delivers SABR across all cancer sites and will consider patients with three or fewer metastases in lung, liver, spine, bone, adrenal or lymph node from any solid tumour.
Dr Ezhil started her post as a substantive consultant in clinical oncology in November 2009, specialising in the management of lung cancer and lymphoma. She has a special interest in respiratory motion management and advanced technical radiotherapy. She completed her research fellowship in advanced technical radiotherapy at the University of Texas MD Anderson Cancer Centre, Houston, Texas, studying the various methods of managing respiratory motion including 4DCT, respiratory gating and other techniques of IGRT. She also gained clinical experience in SABR and had the benefit of learning the indications and benefits of proton therapy.
Dr Ezhil has attended the Stereotactic Body Radiation Therapy Training Programme held at UT Southwestern Medical Centre, Dallas, Texas under the leadership of Timmerman in December 2011 and the SBRT Symposium 2014 held in Amsterdam organised by the Dutch Society of Radiation Oncology in December 2014 to further improve her SABR skills. She attends ASTRO and other national and international conferences on SABR regularly to maintain collaboration with experts in the field of stereotactic radiotherapy and to keep up-to-date with the latest developments and issues in SABR treatments. She has published original articles in oncology journals and presented at national and international meetings. Dr Ezhil led the implementation of the SABR lung service at Royal Surrey County Hospital in January 2012 and has treated over 150 patients. She is currently the SABR lead for the treatment of oligometastases at RSCH and delivers SABR across all cancer sites and will consider patients with 3 or fewer metastases in lung, liver, spine, bone, adrenal or lymph node from any solid tumour.